Chinook Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
36.44
|
|
Average Rating
|
4.90
|
|
# Strong Buys
|
9
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.79
|
0.00
|
0.79
|
100.00%
|
|
2022-09-30
|
-0.63
|
-0.83
|
-0.20
|
-31.75%
|
|
2022-06-30
|
-0.61
|
-0.61
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.67
|
-0.54
|
0.13
|
19.40%
|
|
2021-12-31
|
-0.68
|
0.14
|
0.82
|
120.59%
|
|
2021-09-30
|
-0.84
|
-0.69
|
0.15
|
17.86%
|
|
2021-06-30
|
-0.78
|
-0.97
|
-0.19
|
-24.36%
|
|
2021-03-31
|
-0.44
|
-1.24
|
-0.80
|
-181.82%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-1.98
|
|
2021-12-31
|
-2.76
|
|
2020-12-31
|
-3.64
|
|
2019-12-31
|
-5.10
|
|
2018-12-31
|
-3.69
|
|
2017-12-31
|
-1.26
|
|
2016-12-31
|
-1.40
|
|
2015-12-31
|
-40.42
|